CCL4在肿瘤微环境中影响免疫逃逸的研究进展

免疫治疗已成为当下恶性肿瘤治疗的基石.然而,不同患者对免疫治疗的反应具有较大异质性,并非都能从中获益.当下亟需寻找能高效预测免疫治疗疗效的生物标志物.C-C趋化因子配体4(C-Cchemokineligand 4,CCL4)是一种细胞因子,隶属于炎症性CCL亚家族,主要由免疫细胞、肿瘤细胞分泌,在正常组织中不表达或者弱表达,在多种恶性肿瘤组织中异常高表达.CCL4与其受体C-C趋化因子受体5(C-C chemokine receptor type 5,CCR5)结合后可招募并介导免疫细胞迁移,破坏肿瘤微环境(tumor micro environment,TME)的稳定性,参与致癌并促进肿瘤发...

Full description

Saved in:
Bibliographic Details
Published inZhongguo fei ai za zhi Vol. 27; no. 8; pp. 613 - 621
Main Authors 陈然, 杨新月, 刘倩, 张树才, 马丽
Format Journal Article
LanguageChinese
English
Published No. 154 Anshan Road, Heping District, Tianjin, PRC, 300052 441000 襄阳,湖北医药学院附属襄阳市第一人民医院肿瘤科 20.08.2024
101149 北京,首都医科大学附属北京胸科医院北京市结核病胸部肿瘤研究所肿瘤内科%441000 襄阳,武汉科技大学医学院襄阳市第一人民医院研究生联合培养基地肿瘤科%441000 襄阳,湖北医药学院附属襄阳市第一人民医院肿瘤科%101149 北京,首都医科大学附属北京胸科医院北京市结核病胸部肿瘤研究所肿瘤内科
Editorial board of Chinese Journal of Lung Cancer
Subjects
Review
肿瘤微环境
免疫逃逸
Immune response
免疫应答
Tumor microenvironment
免疫治疗
Immunotherapy
CCL4
Immune escape
Online AccessGet full text
ISSN1009-3419
1999-6187
DOI10.3779/j.issn.1009-3419.2024.106.23

Cover

Abstract 免疫治疗已成为当下恶性肿瘤治疗的基石.然而,不同患者对免疫治疗的反应具有较大异质性,并非都能从中获益.当下亟需寻找能高效预测免疫治疗疗效的生物标志物.C-C趋化因子配体4(C-Cchemokineligand 4,CCL4)是一种细胞因子,隶属于炎症性CCL亚家族,主要由免疫细胞、肿瘤细胞分泌,在正常组织中不表达或者弱表达,在多种恶性肿瘤组织中异常高表达.CCL4与其受体C-C趋化因子受体5(C-C chemokine receptor type 5,CCR5)结合后可招募并介导免疫细胞迁移,破坏肿瘤微环境(tumor micro environment,TME)的稳定性,参与致癌并促进肿瘤发展.在肿瘤免疫微环境中,CCL4可介导并募集单核细胞、巨噬细胞、自然杀伤(natural killer,NK)细胞、T细胞等关键免疫细胞定向迁移,成为影响免疫治疗疗效的潜在重要元素,而具有特定的价值.本文就CCL4在TME中影响免疫逃逸的研究进展进行综述,以期为基础研究及临床诊疗提供线索和参考.
AbstractList 免疫治疗已成为当下恶性肿瘤治疗的基石。然而，不同患者对免疫治疗的反应具有较大异质性，并非都能从中获益。当下亟需寻找能高效预测免疫治疗疗效的生物标志物。C-C趋化因子配体4（C-C chemokine ligand 4, CCL4）是一种细胞因子，隶属于炎症性CCL亚家族，主要由免疫细胞、肿瘤细胞分泌，在正常组织中不表达或者弱表达，在多种恶性肿瘤组织中异常高表达。CCL4与其受体C-C趋化因子受体5（C-C chemokine receptor type 5, CCR5）结合后可招募并介导免疫细胞迁移，破坏肿瘤微环境（tumor microenvironment, TME）的稳定性，参与致癌并促进肿瘤发展。在肿瘤免疫微环境中，CCL4可介导并募集单核细胞、巨噬细胞、自然杀伤（natural killer, NK）细胞、T细胞等关键免疫细胞定向迁移，成为影响免疫治疗疗效的潜在重要元素，而具有特定的价值。本文就CCL4在TME中影响免疫逃逸的研究进展进行综述，以期为基础研究及临床诊疗提供线索和参考。
免疫治疗已成为当下恶性肿瘤治疗的基石.然而,不同患者对免疫治疗的反应具有较大异质性,并非都能从中获益.当下亟需寻找能高效预测免疫治疗疗效的生物标志物.C-C趋化因子配体4(C-Cchemokineligand 4,CCL4)是一种细胞因子,隶属于炎症性CCL亚家族,主要由免疫细胞、肿瘤细胞分泌,在正常组织中不表达或者弱表达,在多种恶性肿瘤组织中异常高表达.CCL4与其受体C-C趋化因子受体5(C-C chemokine receptor type 5,CCR5)结合后可招募并介导免疫细胞迁移,破坏肿瘤微环境(tumor micro environment,TME)的稳定性,参与致癌并促进肿瘤发展.在肿瘤免疫微环境中,CCL4可介导并募集单核细胞、巨噬细胞、自然杀伤(natural killer,NK)细胞、T细胞等关键免疫细胞定向迁移,成为影响免疫治疗疗效的潜在重要元素,而具有特定的价值.本文就CCL4在TME中影响免疫逃逸的研究进展进行综述,以期为基础研究及临床诊疗提供线索和参考.
Abstract_FL Immunotherapy has become the cornerstone of current malignant tumor treatment.However,the response of different patients to immunotherapy is highly heterogeneous,and not all patients can benefit from it.There is an urgent need to find biomarkers that can effectively predict the efficacy of immunotherapy.C-C chemokine ligand 4(CCL4)is a cytokine,belonging to the inflammatory CCL subfamily.It is mainly secreted by immune cells and tumor cells and shows low or no expression in normal tissues but abnormally high expression in various malignant tumor tissues.After binding to CCL4 and its receptor C-C chemokine receptor type 5(CCR5),it can recruit and mediate immune cell migration,destroy the stabili-ty of the tumor microenvironment(TME),participate in carcinogenesis and promote the development of tumors.In the tumor immune microenvironment,CCL4 can mediate and recruit the directed migration of key immune cells such as monocytes,macrophages,natural killer(NK)cells,and T cells,which makes it a potentially important element affecting the efficacy of im-munotherapy and has specific value.This paper reviews the research progresses of CCL4's effects on immune escape in TME,in order to provide clues and references for basic research and clinical diagnosis and treatment.
Author 杨新月
马丽
刘倩
陈然
张树才
AuthorAffiliation 441000 襄阳,湖北医药学院附属襄阳市第一人民医院肿瘤科;101149 北京,首都医科大学附属北京胸科医院北京市结核病胸部肿瘤研究所肿瘤内科%441000 襄阳,武汉科技大学医学院襄阳市第一人民医院研究生联合培养基地肿瘤科%441000 襄阳,湖北医药学院附属襄阳市第一人民医院肿瘤科%101149 北京,首都医科大学附属北京胸科医院北京市结核病胸部肿瘤研究所肿瘤内科
AuthorAffiliation_xml – name: 441000 襄阳,湖北医药学院附属襄阳市第一人民医院肿瘤科;101149 北京,首都医科大学附属北京胸科医院北京市结核病胸部肿瘤研究所肿瘤内科%441000 襄阳,武汉科技大学医学院襄阳市第一人民医院研究生联合培养基地肿瘤科%441000 襄阳,湖北医药学院附属襄阳市第一人民医院肿瘤科%101149 北京,首都医科大学附属北京胸科医院北京市结核病胸部肿瘤研究所肿瘤内科
Author_FL Li MA
Ran CHEN
Xinyue YANG
Qian LIU
Shucai ZHANG
Author_FL_xml – sequence: 1
  fullname: Ran CHEN
– sequence: 2
  fullname: Xinyue YANG
– sequence: 3
  fullname: Qian LIU
– sequence: 4
  fullname: Shucai ZHANG
– sequence: 5
  fullname: Li MA
Author_xml – sequence: 1
  fullname: 陈然
– sequence: 2
  fullname: 杨新月
– sequence: 3
  fullname: 刘倩
– sequence: 4
  fullname: 张树才
– sequence: 5
  fullname: 马丽
BookMark eNpVkDtLw1AcxS9SsQ_9FoJT4n3lPlxEii8ouHQPN-1NTWmTkljFTsXqWBcfiDqIOCii0kW6aL-MIe23MFIdnM75cw4__pw8yPiBrwFYRNAknMvluulFkW8iCKVBKJImhpimJzMxmQE5JKU0GBI8k_q_Thbko6gOIcOS0DmQJZIggS2aAyvFYonGt4_jo1Fy9RB_vianb_F972v4En8M4rN-fNJPLp8n3d6kO0yuj5O78-TpfTy6iQcX82DWVY1IL_xqAZQ31svFLaO0s7ldXCsZLSGEwQRllmLcEkpqjBlTlqK0QrjQkjIiGeJYadfFDlMUO5YLqeYCUocqSGVVkQJYnWJbbaepqxXt74WqYbdCr6nCQztQnv0_8b1duxbs2whRbDHOUsLSlHCgfFf5NbsetEM_fdnu1FzV6fwMCAWEgnwD8M15vw
ContentType Journal Article
Copyright Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
版权所有 © 2024《中国肺癌杂志》编辑部 Copyright © 2024, Chinese Journal of Lung Cancer. 2024 Chinese Journal of Lung Cancer
Copyright_xml – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
– notice: 版权所有 © 2024《中国肺癌杂志》编辑部 Copyright © 2024, Chinese Journal of Lung Cancer. 2024 Chinese Journal of Lung Cancer
DBID 2B.
4A8
92I
93N
PSX
TCJ
5PM
DOI 10.3779/j.issn.1009-3419.2024.106.23
DatabaseName Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
PubMed Central (Full Participant titles)
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitle_FL Research Progresses on the Effects of CCL4 on Immune Escape in Tumor Microenvironment
EISSN 1999-6187
EndPage 621
ExternalDocumentID PMC11425676
zgfazz202408008
GrantInformation_xml – fundername: 2024年湖北省自然科学基金项目; Hubei Provincial Natural Science Foundation
  grantid: 2024AFB987
GroupedDBID ---
-05
04C
29R
2B.
2WC
4A8
5GY
5VS
6PF
92F
92I
93N
AAWTL
ABUWG
ACGFS
AFKRA
ALMA_UNASSIGNED_HOLDINGS
BENPR
BPHCQ
BVBZV
C1A
CCEZO
CCPQU
CIEJG
CW9
DIK
E3Z
EBD
EIHBH
EMOBN
EOJEC
F5P
GROUPED_DOAJ
HYE
IPNFZ
KQ8
KWQ
OBODZ
OK1
PGMZT
PHGZM
PHGZT
PIMPY
PMFND
PQQKQ
PROAC
PSX
RIG
RNS
RPM
TCJ
TGQ
U1G
U5O
5PM
OVT
PUEGO
ID FETCH-LOGICAL-p888-68465a6758a9e2266a5a44c378e946396172aeff2b6a42b5f04e7804b4a049da3
ISSN 1009-3419
IngestDate Tue Sep 30 17:07:04 EDT 2025
Thu May 29 03:56:18 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords 肿瘤微环境
免疫逃逸
Immune response
免疫应答
Tumor microenvironment
免疫治疗
Immunotherapy
CCL4
Immune escape
Language Chinese
English
License This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-p888-68465a6758a9e2266a5a44c378e946396172aeff2b6a42b5f04e7804b4a049da3
OpenAccessLink http://dx.doi.org/10.3779/j.issn.1009-3419.2024.106.23
PMID 39318254
PageCount 9
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_11425676
wanfang_journals_zgfazz202408008
PublicationCentury 2000
PublicationDate 20240820
PublicationDateYYYYMMDD 2024-08-20
PublicationDate_xml – month: 8
  year: 2024
  text: 20240820
  day: 20
PublicationDecade 2020
PublicationPlace No. 154 Anshan Road, Heping District, Tianjin, PRC, 300052
PublicationPlace_xml – name: No. 154 Anshan Road, Heping District, Tianjin, PRC, 300052
PublicationTitle Zhongguo fei ai za zhi
PublicationTitle_FL Chinese Journal of Lung Cancer
PublicationYear 2024
Publisher 441000 襄阳,湖北医药学院附属襄阳市第一人民医院肿瘤科
101149 北京,首都医科大学附属北京胸科医院北京市结核病胸部肿瘤研究所肿瘤内科%441000 襄阳,武汉科技大学医学院襄阳市第一人民医院研究生联合培养基地肿瘤科%441000 襄阳,湖北医药学院附属襄阳市第一人民医院肿瘤科%101149 北京,首都医科大学附属北京胸科医院北京市结核病胸部肿瘤研究所肿瘤内科
Editorial board of Chinese Journal of Lung Cancer
Publisher_xml – name: 441000 襄阳,湖北医药学院附属襄阳市第一人民医院肿瘤科
– name: 101149 北京,首都医科大学附属北京胸科医院北京市结核病胸部肿瘤研究所肿瘤内科%441000 襄阳,武汉科技大学医学院襄阳市第一人民医院研究生联合培养基地肿瘤科%441000 襄阳,湖北医药学院附属襄阳市第一人民医院肿瘤科%101149 北京,首都医科大学附属北京胸科医院北京市结核病胸部肿瘤研究所肿瘤内科
– name: Editorial board of Chinese Journal of Lung Cancer
SSID ssj0062934
ssib002262905
ssib044765436
ssib001103766
ssib038074678
ssib051369142
Score 2.4233854
Snippet 免疫治疗已成为当下恶性肿瘤治疗的基石.然而,不同患者对免疫治疗的反应具有较大异质性,并非都能从中获益.当下亟需寻找能高效预测免疫治疗疗效的生物标志物.C-C趋化因子配...
免疫治疗已成为当下恶性肿瘤治疗的基石。然而，不同患者对免疫治疗的反应具有较大异质性，并非都能从中获益。当下亟需寻找能高效预测免疫治疗疗效的生物标志物。C-C趋化因子...
SourceID pubmedcentral
wanfang
SourceType Open Access Repository
Aggregation Database
StartPage 613
SubjectTerms Review
Title CCL4在肿瘤微环境中影响免疫逃逸的研究进展
URI https://d.wanfangdata.com.cn/periodical/zgfazz202408008
https://pubmed.ncbi.nlm.nih.gov/PMC11425676
Volume 27
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1999-6187
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0062934
  issn: 1009-3419
  databaseCode: KQ8
  dateStart: 20080101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1999-6187
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0062934
  issn: 1009-3419
  databaseCode: DOA
  dateStart: 20080101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1999-6187
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0062934
  issn: 1009-3419
  databaseCode: DIK
  dateStart: 19980101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 1999-6187
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssib044765436
  issn: 1009-3419
  databaseCode: M~E
  dateStart: 19980101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 1999-6187
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0062934
  issn: 1009-3419
  databaseCode: RPM
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVPQU
  databaseName: East & South Asia Database
  customDbUrl:
  eissn: 1999-6187
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0062934
  issn: 1009-3419
  databaseCode: BVBZV
  dateStart: 19980101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/eastsouthasia
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central - New (Subscription)
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 1999-6187
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0062934
  issn: 1009-3419
  databaseCode: BENPR
  dateStart: 19980101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR3LbtQw0CqtqLggnqI8qh7wCe2SOI5jc4uzqSoEFUJF6m2VbJKWy1JBK6Q9VRSO5cJDCDggxAGEAPWCeoHyMUTb_gUzTjabPsRLWkUTP2Y8M7bH9nomhFy0WZy40us0GE-8Bld2BvOgyhpJzGKWeImVFtE-Z8XMLX513p0fOfSjdmtpZTludnoH-pX8j1YhDfSKXrL_oNkKKSQADPqFJ2gYnn-l4yC4xmnoUhVQX9JQUsmonqahR5WkvsnSIfVDTJEATGOKz6h0aMiphjItU6ZFtW3wOFSaFOkaAPAI6msaKrwQgbUMABUxy6eSI-BbVBWAolpgM6ANShvMNi0-bjlY_-6iC2WAdNls3-AE_AENBVUtTEQMgKoylUgfixj6QFyLYY6pg1IQ2GhtGSCgUg6LuFgTJIOABa2t5-gA-YA6yI2NgARCrfqhCON4ysusqhvDGg-m-kvIge8aYShErx3ot4hBK2wKUguAiRLQ2nDcGmgDAFHyBZopGeQD4YUHIMcsIzMUeYC_QqjAEwK-kaURgbJrRCsS-7sJ4AHYrhko_DMLY_DVLVgRXaEcqbJmjkTh51uubEThi77XaGLISWM0kUCzItBEucKraDJnuFiornD2FrKo12MmRJ7xth9jYFetUTKmw9kbN4dLcnRErR8RMMHU0Mbg9w7AVlc2gHMPvZ2r8q7tCGXzKiQcVC5uigyaOQ7zTcHD5d9xsP_O8-H7UTeLugu15eTcMXK03AdO-cWgPk5GeosnyPj18qbLSXIFx3b--v32g63-i3f598_9x1_yt2s_Nz_l3zbyJ-v5o_X-8487q2s7q5v9lw_7b572P3zd3nqVbzw7Reamw7lgplF-56SxJGFGE7AFcCPcuEcqBfGIyI047zieTBWHDQTuMaI0y1gsIs5iN7N4imHDYh7B9j6JnNNktHunm54hU1ncsRObW0nGXA5glFkx46kTd2LFndibIHKXFNpLRUibNgaZ353Tvb1ogs2jr70rPDFBpkqBtcsZ8F57Tx84--ci58iR4XA9T0aX766kF2BVvxxPlh1n0pyK_QLdaLzU
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=CCL4%E5%9C%A8%E8%82%BF%E7%98%A4%E5%BE%AE%E7%8E%AF%E5%A2%83%E4%B8%AD%E5%BD%B1%E5%93%8D%E5%85%8D%E7%96%AB%E9%80%83%E9%80%B8%E7%9A%84%E7%A0%94%E7%A9%B6%E8%BF%9B%E5%B1%95&rft.jtitle=%E4%B8%AD%E5%9B%BD%E8%82%BA%E7%99%8C%E6%9D%82%E5%BF%97&rft.au=%E9%99%88%E7%84%B6&rft.au=%E6%9D%A8%E6%96%B0%E6%9C%88&rft.au=%E5%88%98%E5%80%A9&rft.au=%E5%BC%A0%E6%A0%91%E6%89%8D&rft.date=2024-08-20&rft.pub=441000+%E8%A5%84%E9%98%B3%2C%E6%B9%96%E5%8C%97%E5%8C%BB%E8%8D%AF%E5%AD%A6%E9%99%A2%E9%99%84%E5%B1%9E%E8%A5%84%E9%98%B3%E5%B8%82%E7%AC%AC%E4%B8%80%E4%BA%BA%E6%B0%91%E5%8C%BB%E9%99%A2%E8%82%BF%E7%98%A4%E7%A7%91&rft.issn=1009-3419&rft.volume=27&rft.issue=8&rft.spage=613&rft.epage=621&rft_id=info:doi/10.3779%2Fj.issn.1009-3419.2024.106.23&rft.externalDocID=zgfazz202408008
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fzgfazz%2Fzgfazz.jpg